Literature DB >> 28797700

4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers.

Ruben T H M Larue1, Lien Van De Voorde2, Janna E van Timmeren2, Ralph T H Leijenaar2, Maaike Berbée2, Meindert N Sosef3, Wendy M J Schreurs4, Wouter van Elmpt2, Philippe Lambin2.   

Abstract

BACKGROUND AND
PURPOSE: Quantitative tissue characteristics derived from medical images, also called radiomics, contain valuable prognostic information in several tumour-sites. The large number of features available increases the risk of overfitting. Typically test-retest CT-scans are used to reduce dimensionality and select robust features. However, these scans are not always available. We propose to use different phases of respiratory-correlated 4D CT-scans (4DCT) as alternative.
MATERIALS AND METHODS: In test-retest CT-scans of 26 non-small cell lung cancer (NSCLC) patients and 4DCT-scans (8 breathing phases) of 20 NSCLC and 20 oesophageal cancer patients, 1045 radiomics features of the primary tumours were calculated. A concordance correlation coefficient (CCC) >0.85 was used to identify robust features. Correlation with prognostic value was tested using univariate cox regression in 120 oesophageal cancer patients.
RESULTS: Features based on unfiltered images demonstrated greater robustness than wavelet-filtered features. In total 63/74 (85%) unfiltered features and 268/299 (90%) wavelet features stable in the 4D-lung dataset were also stable in the test-retest dataset. In oesophageal cancer 397/1045 (38%) features were robust, of which 108 features were significantly associated with overall-survival.
CONCLUSION: 4DCT-scans can be used as alternative to eliminate unstable radiomics features as first step in a feature selection procedure. Feature robustness is tumour-site specific and independent of prognostic value.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4D-CT; Feature stability; Lung cancer; Oesophageal cancer; Radiomics; Test-retest

Mesh:

Year:  2017        PMID: 28797700     DOI: 10.1016/j.radonc.2017.07.023

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

1.  Extracting and Selecting Robust Radiomic Features from PET/MR Images in Nasopharyngeal Carcinoma.

Authors:  Pengfei Yang; Lei Xu; Zuozhen Cao; Yidong Wan; Yi Xue; Yangkang Jiang; Eric Yen; Chen Luo; Jing Wang; Yi Rong; Tianye Niu
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

Review 2.  Radiomics: from qualitative to quantitative imaging.

Authors:  William Rogers; Sithin Thulasi Seetha; Turkey A G Refaee; Relinde I Y Lieverse; Renée W Y Granzier; Abdalla Ibrahim; Simon A Keek; Sebastian Sanduleanu; Sergey P Primakov; Manon P L Beuque; Damiënne Marcus; Alexander M A van der Wiel; Fadila Zerka; Cary J G Oberije; Janita E van Timmeren; Henry C Woodruff; Philippe Lambin
Journal:  Br J Radiol       Date:  2020-02-26       Impact factor: 3.039

3.  Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessment.

Authors:  Nathaniel Barry; Pejman Rowshanfarzad; Roslyn J Francis; Anna K Nowak; Martin A Ebert
Journal:  Phys Eng Sci Med       Date:  2021-08-26

Review 4.  Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT.

Authors:  Robert J O'Shea; Chris Rookyard; Sam Withey; Gary J R Cook; Sophia Tsoka; Vicky Goh
Journal:  Insights Imaging       Date:  2022-06-17

5.  Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.

Authors:  Xiaozhen Yang; Chunwang Yuan; Yinghua Zhang; Zhenchang Wang
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

Review 6.  Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype.

Authors:  Isabella Fornacon-Wood; Corinne Faivre-Finn; James P B O'Connor; Gareth J Price
Journal:  Lung Cancer       Date:  2020-06-02       Impact factor: 5.705

7.  [Formula: see text]: deep learning-based radiomics for the time-to-event outcome prediction in lung cancer.

Authors:  Parnian Afshar; Arash Mohammadi; Pascal N Tyrrell; Patrick Cheung; Ahmed Sigiuk; Konstantinos N Plataniotis; Elsie T Nguyen; Anastasia Oikonomou
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

8.  Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trial.

Authors:  Jurgen Peerlings; Henry C Woodruff; Jessica M Winfield; Abdalla Ibrahim; Bernard E Van Beers; Arend Heerschap; Alan Jackson; Joachim E Wildberger; Felix M Mottaghy; Nandita M DeSouza; Philippe Lambin
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

9.  Gray-level discretization impacts reproducible MRI radiomics texture features.

Authors:  Loïc Duron; Daniel Balvay; Saskia Vande Perre; Afef Bouchouicha; Julien Savatovsky; Jean-Claude Sadik; Isabelle Thomassin-Naggara; Laure Fournier; Augustin Lecler
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

10.  Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction.

Authors:  Qian Du; Michael Baine; Kyle Bavitz; Josiah McAllister; Xiaoying Liang; Hongfeng Yu; Jeffrey Ryckman; Lina Yu; Hengle Jiang; Sumin Zhou; Chi Zhang; Dandan Zheng
Journal:  PLoS One       Date:  2019-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.